Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.
Revolution Medicines is seeking an Executive Director of AI/ML Research & Scientific Computing to lead the development of AI/ML strategies for precision oncology. The role involves defining the AI/ML strategy, overseeing implementation of advanced analytics, and building a world-class team. It will focus on unlocking data insights for early discovery and pipeline acceleration, influencing early design innovation and strategic portfolio decisions.
Revolution Medicines is dedicated to discovering, developing, and delivering innovative targeted medicines for cancer patients. The company focuses on RAS-addicted cancers, which represent 30 percent of new human cancer diagnoses. Revolutionaries work tirelessly to develop cutting-edge therapeutic approaches, setting them apart in the industry with their commitment to tackling some of the toughest cancers.
Flagship Pioneering